JP2013531978A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013531978A5 JP2013531978A5 JP2013512251A JP2013512251A JP2013531978A5 JP 2013531978 A5 JP2013531978 A5 JP 2013531978A5 JP 2013512251 A JP2013512251 A JP 2013512251A JP 2013512251 A JP2013512251 A JP 2013512251A JP 2013531978 A5 JP2013531978 A5 JP 2013531978A5
- Authority
- JP
- Japan
- Prior art keywords
- pdhk
- nucleic acid
- acid sequence
- cell
- heterologous nucleic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000053067 Pyruvate Dehydrogenase Acetyl-Transferring Kinase Human genes 0.000 claims 47
- 101710159466 [Pyruvate dehydrogenase (acetyl-transferring)] kinase, mitochondrial Proteins 0.000 claims 47
- 210000004027 cell Anatomy 0.000 claims 40
- 150000007523 nucleic acids Chemical group 0.000 claims 40
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 39
- 108020004459 Small interfering RNA Proteins 0.000 claims 32
- 239000004055 small Interfering RNA Substances 0.000 claims 32
- 238000000034 method Methods 0.000 claims 29
- 102000003855 L-lactate dehydrogenase Human genes 0.000 claims 26
- 108700023483 L-lactate dehydrogenases Proteins 0.000 claims 26
- 210000004748 cultured cell Anatomy 0.000 claims 24
- 101100243116 Homo sapiens PDK1 gene Proteins 0.000 claims 10
- 101100463123 Homo sapiens PDK3 gene Proteins 0.000 claims 10
- 101001117143 Homo sapiens [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial Proteins 0.000 claims 10
- 102100024148 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial Human genes 0.000 claims 10
- 102100024150 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial Human genes 0.000 claims 10
- 102100034824 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial Human genes 0.000 claims 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 10
- 238000004519 manufacturing process Methods 0.000 claims 10
- 229920001184 polypeptide Polymers 0.000 claims 8
- 102000004196 processed proteins & peptides Human genes 0.000 claims 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims 8
- 235000014655 lactic acid Nutrition 0.000 claims 5
- 239000004310 lactic acid Substances 0.000 claims 5
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims 3
- 101150041530 ldha gene Proteins 0.000 claims 3
- 101100463125 Homo sapiens PDK4 gene Proteins 0.000 claims 2
- 102100034825 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial Human genes 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 210000004962 mammalian cell Anatomy 0.000 claims 2
- 238000013518 transcription Methods 0.000 claims 2
- 230000035897 transcription Effects 0.000 claims 2
- 101710088194 Dehydrogenase Proteins 0.000 claims 1
- 108091000080 Phosphotransferase Proteins 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 230000002222 downregulating effect Effects 0.000 claims 1
- 230000030279 gene silencing Effects 0.000 claims 1
- 102000020233 phosphotransferase Human genes 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34972710P | 2010-05-28 | 2010-05-28 | |
| US61/349,727 | 2010-05-28 | ||
| PCT/US2011/038191 WO2011150241A2 (en) | 2010-05-28 | 2011-05-26 | Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016227876A Division JP6325060B2 (ja) | 2010-05-28 | 2016-11-24 | Ｌｄｈ及びｐｄｈｋ発現を下方制御することによる乳酸レベルの低下及びポリペプチド生産の増加 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013531978A JP2013531978A (ja) | 2013-08-15 |
| JP2013531978A5 true JP2013531978A5 (enExample) | 2014-07-10 |
| JP6050226B2 JP6050226B2 (ja) | 2016-12-21 |
Family
ID=45004831
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013512251A Active JP6050226B2 (ja) | 2010-05-28 | 2011-05-26 | Ｌｄｈ及びｐｄｈｋ発現を下方制御することによる乳酸レベルの低下及びポリペプチド生産の増加 |
| JP2016227876A Active JP6325060B2 (ja) | 2010-05-28 | 2016-11-24 | Ｌｄｈ及びｐｄｈｋ発現を下方制御することによる乳酸レベルの低下及びポリペプチド生産の増加 |
| JP2018076234A Active JP6706642B2 (ja) | 2010-05-28 | 2018-04-11 | Ｌｄｈ及びｐｄｈｋ発現を下方制御することによる乳酸レベルの低下及びポリペプチド生産の増加 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016227876A Active JP6325060B2 (ja) | 2010-05-28 | 2016-11-24 | Ｌｄｈ及びｐｄｈｋ発現を下方制御することによる乳酸レベルの低下及びポリペプチド生産の増加 |
| JP2018076234A Active JP6706642B2 (ja) | 2010-05-28 | 2018-04-11 | Ｌｄｈ及びｐｄｈｋ発現を下方制御することによる乳酸レベルの低下及びポリペプチド生産の増加 |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US9487809B2 (enExample) |
| EP (1) | EP2576580B1 (enExample) |
| JP (3) | JP6050226B2 (enExample) |
| KR (3) | KR101989762B1 (enExample) |
| CN (1) | CN102985437B (enExample) |
| BR (1) | BR112012030197A2 (enExample) |
| CA (1) | CA2800728C (enExample) |
| DK (1) | DK2576580T3 (enExample) |
| ES (1) | ES2599412T3 (enExample) |
| HU (1) | HUE030820T2 (enExample) |
| MX (3) | MX343604B (enExample) |
| PL (1) | PL2576580T3 (enExample) |
| RU (1) | RU2614125C2 (enExample) |
| SI (1) | SI2576580T1 (enExample) |
| WO (1) | WO2011150241A2 (enExample) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2831860B2 (ja) | 1991-03-29 | 1998-12-02 | 株式会社東芝 | 連続ラインの連続式冷却槽温度制御装置 |
| US8911964B2 (en) | 2006-09-13 | 2014-12-16 | Abbvie Inc. | Fed-batch method of making human anti-TNF-alpha antibody |
| SG174804A1 (enExample) | 2006-09-13 | 2011-10-28 | Abbott Lab | |
| NZ592095A (en) | 2008-10-20 | 2013-01-25 | Abbott Lab | Isolation and purification of il-12 and tnf-alpha antibodies using protein a affinity chromatography |
| TW201028433A (en) | 2008-10-20 | 2010-08-01 | Abbott Lab | Viral inactivation during purification of antibodies |
| MX343604B (es) | 2010-05-28 | 2016-11-11 | Genentech Inc | Disminuir nivel de lactato e incrementar producción de polipéptidos por regulación a la baja de la expresión de lactato dehidrogenasa y piruvato dehidrogenasa quinasa. |
| WO2012149197A2 (en) | 2011-04-27 | 2012-11-01 | Abbott Laboratories | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
| US9181572B2 (en) | 2012-04-20 | 2015-11-10 | Abbvie, Inc. | Methods to modulate lysine variant distribution |
| US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
| US9150645B2 (en) | 2012-04-20 | 2015-10-06 | Abbvie, Inc. | Cell culture methods to reduce acidic species |
| US9249182B2 (en) | 2012-05-24 | 2016-02-02 | Abbvie, Inc. | Purification of antibodies using hydrophobic interaction chromatography |
| AU2013309506A1 (en) | 2012-09-02 | 2015-03-12 | Abbvie Inc. | Methods to control protein heterogeneity |
| US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
| SG11201507230PA (en) | 2013-03-12 | 2015-10-29 | Abbvie Inc | Human antibodies that bind human tnf-alpha and methods of preparing the same |
| US9499614B2 (en) | 2013-03-14 | 2016-11-22 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides |
| US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
| US8921526B2 (en) | 2013-03-14 | 2014-12-30 | Abbvie, Inc. | Mutated anti-TNFα antibodies and methods of their use |
| AR095196A1 (es) * | 2013-03-15 | 2015-09-30 | Regeneron Pharma | Medio de cultivo celular libre de suero |
| SI3019619T1 (sl) | 2013-07-11 | 2021-12-31 | Modernatx, Inc. | Sestave, ki zajemajo sintetične polinukleotide, ki kodirajo proteine, pozvezane s crispr, in sintetične sgrna, ter metode uporabe |
| WO2015051293A2 (en) | 2013-10-04 | 2015-04-09 | Abbvie, Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
| US11390663B2 (en) | 2013-10-11 | 2022-07-19 | Regeneron Pharmaceuticals, Inc. | Metabolically optimized cell culture |
| PL3055409T3 (pl) * | 2013-10-11 | 2018-10-31 | Regeneron Pharmaceuticals, Inc. | Metabolicznie zoptymalizowana hodowla komórkowa |
| US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
| US8946395B1 (en) | 2013-10-18 | 2015-02-03 | Abbvie Inc. | Purification of proteins using hydrophobic interaction chromatography |
| US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
| US20150139988A1 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
| WO2015142903A2 (en) * | 2014-03-17 | 2015-09-24 | Genentech, Inc. | Method of controlling lactate production with piperdine-dione derivatives |
| EP3204497B1 (en) | 2014-10-10 | 2020-03-11 | Dicerna Pharmaceuticals, Inc. | Therapeutic inhibition of lactate dehydrogenase and agents therefor |
| KR102265924B1 (ko) * | 2014-10-31 | 2021-06-15 | 삼성바이오에피스 주식회사 | Pdk 불활성화에 의한 폴리펩타이드의 생산 |
| KR101978277B1 (ko) * | 2015-02-06 | 2019-05-14 | 경북대학교 산학협력단 | Pdk2를 이용한 여성 갱년기 질환 예방 또는 치료제의 스크리닝 방법 및 상기 방법으로 스크리닝 된 치료제를 유효성분으로 포함하는 여성 갱년기 질환의 예방 또는 치료용 약학적 조성물 |
| CN105368839A (zh) * | 2015-12-22 | 2016-03-02 | 中国人民解放军第三军医大学 | 一种有效抑制小鼠pdk2表达的rna干扰序列及其应用 |
| EP3452080A4 (en) | 2016-05-02 | 2019-10-09 | The Regents of the University of California | MAMMALIAN CELLS WITHOUT LACTATE DEHYDROGENASE ACTIVITY |
| IL273875B2 (en) | 2017-10-13 | 2025-07-01 | Dicerna Pharmaceuticals Inc | Methods and compositions for inhibiting expression of ldha |
| CN107904257B (zh) * | 2017-11-22 | 2021-05-04 | 上海药明生物技术有限公司 | 一种增加cho细胞群蛋白表达量的方法 |
| JP2021505662A (ja) | 2017-12-04 | 2021-02-18 | ザ ジェネラル ホスピタル コーポレイション | 疾患を軽減するための細胞外酸化還元酵素系 |
| MX2020010028A (es) * | 2018-03-29 | 2020-10-14 | Genentech Inc | Actividad lactogenica modulada en celulas de mamifero. |
| AU2020306672B2 (en) * | 2019-06-26 | 2023-08-24 | F. Hoffmann-La Roche Ag | Mammalian cell lines with SIRT-1 gene knockout |
| US12297451B1 (en) | 2019-10-25 | 2025-05-13 | Regeneron Pharmaceuticals, Inc. | Cell culture medium |
| WO2021229502A1 (en) | 2020-05-15 | 2021-11-18 | Crispr Therapeutics Ag | Messenger rna encoding cas9 for use in genome-editing systems |
| CN115948404B (zh) * | 2023-02-01 | 2024-06-04 | 重庆医科大学 | 一种抑制环状RNA circPDHK1的siRNA及其用途 |
| EP4574966A1 (en) * | 2023-12-18 | 2025-06-25 | Good Meat, Inc. | Engineered cell lines for the production of cultivated meat |
Family Cites Families (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US30985A (en) | 1860-12-18 | Thomas l | ||
| USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
| FR2413974A1 (fr) | 1978-01-06 | 1979-08-03 | David Bernard | Sechoir pour feuilles imprimees par serigraphie |
| US4515893A (en) | 1979-04-26 | 1985-05-07 | Ortho Pharmaceutical Corporation | Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
| US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
| US5672347A (en) | 1984-07-05 | 1997-09-30 | Genentech, Inc. | Tumor necrosis factor antagonists and their use |
| US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
| GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| US5091178A (en) | 1986-02-21 | 1992-02-25 | Oncogen | Tumor therapy with biologically active anti-tumor antibodies |
| US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
| GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| EP0308936B1 (en) | 1987-09-23 | 1994-07-06 | Bristol-Myers Squibb Company | Antibody heteroconjugates for the killing of HIV-infected cells |
| US5091313A (en) | 1988-08-05 | 1992-02-25 | Tanox Biosystems, Inc. | Antigenic epitopes of IgE present on B cell but not basophil surface |
| US5720937A (en) | 1988-01-12 | 1998-02-24 | Genentech, Inc. | In vivo tumor detection assay |
| ATE113846T1 (de) | 1988-06-21 | 1994-11-15 | Genentech Inc | Therapeutische zusammensetzungen für die behandlung von myocard-infarkten. |
| AU632065B2 (en) | 1988-09-23 | 1992-12-17 | Novartis Vaccines And Diagnostics, Inc. | Cell culture medium for enhanced cell growth, culture longevity and product expression |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
| DE69029036T2 (de) | 1989-06-29 | 1997-05-22 | Medarex Inc | Bispezifische reagenzien für die aids-therapie |
| US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| WO1992020373A1 (en) | 1991-05-14 | 1992-11-26 | Repligen Corporation | Heteroconjugate antibodies for treatment of hiv infection |
| ES2296839T3 (es) | 1991-08-14 | 2008-05-01 | Genentech Inc. | Variantes de inmunoglobulinas para receptores fc-epsilon especificos. |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| ATE419355T1 (de) | 1992-02-06 | 2009-01-15 | Novartis Vaccines & Diagnostic | Marker für krebs und biosynthetisches bindeprotein dafür |
| ATE161192T1 (de) | 1992-08-21 | 1998-01-15 | Genentech Inc | Verfahren zur behandlung einer durch lfa-1 vermittelten störung |
| US5736137A (en) | 1992-11-13 | 1998-04-07 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| WO1995016203A2 (en) | 1993-12-10 | 1995-06-15 | Genentech, Inc. | Methods for diagnosis of allergy and screening of anti-allergy therapeutics |
| AP660A (en) | 1994-01-18 | 1998-08-18 | Genentech Inc | A method of treatment of parasitic infection using IgE antagonists. |
| CA2181787A1 (en) | 1994-03-03 | 1995-09-08 | Claire M. Doerschuk | Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| IL117645A (en) | 1995-03-30 | 2005-08-31 | Genentech Inc | Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration |
| CA2222231A1 (en) | 1995-06-07 | 1996-12-19 | Imclone Systems Incorporated | Antibody and antibody fragments for inhibiting the growth of tumors |
| AU724449B2 (en) | 1996-01-23 | 2000-09-21 | Genentech Inc. | Anti-CD18 antibodies for use against stroke |
| US5726856A (en) | 1996-02-28 | 1998-03-10 | General Electric Company | Hexasubstituted guanidinium salts and ultracapacitors employing them as electrolytes |
| US5714388A (en) | 1996-08-14 | 1998-02-03 | Bayer Corporation | Apparatus and method for detecting chemiluminescent light |
| US7147851B1 (en) | 1996-08-15 | 2006-12-12 | Millennium Pharmaceuticals, Inc. | Humanized immunoglobulin reactive with α4β7 integrin |
| DK1516629T3 (da) | 1996-11-27 | 2013-06-03 | Genentech Inc | Humaniseret anti-CD-11a antibodies |
| ATE293640T1 (de) | 1997-04-07 | 2005-05-15 | Genentech Inc | Anti-vegf antikörper |
| ES2293682T5 (es) | 1997-05-15 | 2011-11-17 | Genentech, Inc. | Anticuerpo anti-apo2. |
| US6946129B1 (en) | 1999-06-08 | 2005-09-20 | Seattle Genetics, Inc. | Recombinant anti-CD40 antibody and uses thereof |
| JP2003502387A (ja) | 1999-06-17 | 2003-01-21 | ザ ユニバーシティ オブ バーモント アンド ステイト アグリカルチュラル カレッジ | プライミングされた抗原特異的ｔ細胞またはｂ細胞を用いる自己養子免疫療法 |
| ES2329437T3 (es) | 1999-06-25 | 2009-11-26 | Genentech, Inc. | Anticuerpos anti-erbb2 humanizados y tratamiento con anticuerpos anti-erbb2. |
| CN1413220A (zh) | 1999-10-29 | 2003-04-23 | 杰南技术公司 | 抗前列腺干细胞抗原(psca)抗体组合物及其应用方法 |
| AU2001275897A1 (en) * | 2000-07-12 | 2002-01-21 | Immunex Corporation | Improvement of cell culture performance |
| ES2566561T3 (es) * | 2001-07-12 | 2016-04-13 | University Of Massachusetts | Producción in vivo de ARN pequeños de interferencia que median el silenciamiento génico |
| WO2006085942A2 (en) | 2004-06-17 | 2006-08-17 | The Regents Of The University Of California | Compositions and methods for regulating gene transcription |
| US20090209618A1 (en) * | 2004-10-08 | 2009-08-20 | Dang Chi V | Pyruvate dehydrogenase kinases as therapeutic targets for cancer and ischemic diseases |
| MX2010001319A (es) * | 2007-08-07 | 2010-06-01 | Chugai Pharmaceutical Co Ltd | Metodo para producir proteinas heterogeneas. |
| ES2557903T3 (es) * | 2008-06-13 | 2016-01-29 | Janssen Biotech, Inc. | Métodos para obtener una alta densidad celular viable en cultivos celulares de mamíferos |
| MX2011002638A (es) * | 2008-09-15 | 2011-04-05 | Genentech Inc | Composiciones y metodos para regular osmolaridad celular. |
| MX343604B (es) | 2010-05-28 | 2016-11-11 | Genentech Inc | Disminuir nivel de lactato e incrementar producción de polipéptidos por regulación a la baja de la expresión de lactato dehidrogenasa y piruvato dehidrogenasa quinasa. |
| WO2015198451A1 (ja) | 2014-06-26 | 2015-12-30 | 楽天株式会社 | 情報処理装置、情報処理方法及び情報処理プログラム |
-
2011
- 2011-05-26 MX MX2012013579A patent/MX343604B/es active IP Right Grant
- 2011-05-26 PL PL11787435T patent/PL2576580T3/pl unknown
- 2011-05-26 RU RU2012157307A patent/RU2614125C2/ru active
- 2011-05-26 WO PCT/US2011/038191 patent/WO2011150241A2/en not_active Ceased
- 2011-05-26 KR KR1020187016873A patent/KR101989762B1/ko not_active Expired - Fee Related
- 2011-05-26 CA CA2800728A patent/CA2800728C/en active Active
- 2011-05-26 HU HUE11787435A patent/HUE030820T2/en unknown
- 2011-05-26 EP EP11787435.4A patent/EP2576580B1/en active Active
- 2011-05-26 DK DK11787435.4T patent/DK2576580T3/en active
- 2011-05-26 MX MX2016014767A patent/MX374851B/es unknown
- 2011-05-26 CN CN201180026517.2A patent/CN102985437B/zh active Active
- 2011-05-26 KR KR1020127033948A patent/KR101869987B1/ko not_active Expired - Fee Related
- 2011-05-26 JP JP2013512251A patent/JP6050226B2/ja active Active
- 2011-05-26 KR KR1020197016381A patent/KR20190067277A/ko not_active Withdrawn
- 2011-05-26 BR BR112012030197A patent/BR112012030197A2/pt not_active Application Discontinuation
- 2011-05-26 ES ES11787435.4T patent/ES2599412T3/es active Active
- 2011-05-26 SI SI201131017A patent/SI2576580T1/sl unknown
-
2012
- 2012-11-22 MX MX2020009460A patent/MX2020009460A/es unknown
- 2012-11-28 US US13/688,075 patent/US9487809B2/en active Active
-
2016
- 2016-09-16 US US15/268,424 patent/US10011856B2/en active Active
- 2016-11-24 JP JP2016227876A patent/JP6325060B2/ja active Active
-
2018
- 2018-04-11 JP JP2018076234A patent/JP6706642B2/ja active Active
- 2018-05-31 US US15/994,950 patent/US10704071B2/en active Active
-
2020
- 2020-05-29 US US16/888,344 patent/US11046987B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013531978A5 (enExample) | ||
| RU2012157307A (ru) | Снижение уровня лактата и увеличение продукции полипептида путем ингибирования экспрессии лактатдегидрогеназы и киназы пируватдегидрогеназы | |
| JP2023182587A5 (enExample) | ||
| JP2010110331A5 (enExample) | ||
| JP2012503478A5 (enExample) | ||
| MY169935A (en) | "a method for reducing heterogeneity of antibodies and a process of producing the antibodies thereof" | |
| JP2012065652A5 (enExample) | ||
| BR112015019950A2 (pt) | Método para gerar linhagem de células-tronco embrionárias (es) de rato, e, cultura in vitro | |
| MY166973A (en) | Methods for reducing accumulation of lactate during culturing and method for producing polypeptide | |
| MY172288A (en) | Cell systems and methods for improving fatty acid synthesis by expression of dehydrogenases | |
| Duan et al. | Bioengineered non-coding RNA agent (BERA) in action | |
| Liu et al. | Development of genetic tools in glucoamylase-hyperproducing industrial Aspergillus niger strains | |
| US20160177300A1 (en) | Means and methods for the generation of mammalian producer cells for the production of recombinant proteins | |
| CN103146525B (zh) | 绵柔型复合多微功能曲生产方法 | |
| CN104152402A (zh) | 一种半滑舌鳎伪雄鱼性腺细胞系的构建与应用方法 | |
| JP2014027888A5 (enExample) | ||
| CN108841864A (zh) | 一种利用rna干扰机制的分子传感器 | |
| CN103255238A (zh) | 一种控制哺乳动物细胞乳酸生成的方法 | |
| CN103361352A (zh) | 鹅原代肝细胞scd1基因沉默试剂盒及其应用 | |
| CN116121301A (zh) | miRNA在CHO细胞重组蛋白表达中的应用 | |
| CN104232804B (zh) | 一种梯度变温诱导提高透明质酸酶表达量的方法 | |
| Falco et al. | Fed-batch production of endoglucanase with a recombinant industrial strain of the yeast Saccharomyces cerevisiae | |
| Tian et al. | RNAi-based Boolean gates in the yeast Saccharomyces cerevisiae | |
| Castillo-Mendieta et al. | Upgrading non-conventional yeasts into valuable biofactories | |
| JP5828447B2 (ja) | エタノールの製造方法 |